The Aplio i900/i800/i700 Diagnostic Ultrasound System, Software V6.5 by Canon Medical Systems Corporation, is a high-quality diagnostic ultrasound system that provides detailed visualization of structures and dynamic processes in the human body. It supports multiple ultrasound modes and is suitable for use in hospitals and clinical settings, aiding clinicians in diagnosing conditions across areas including fetal, abdominal, cardiac, musculoskeletal, vascular, breast, and more.
The system is indicated for visualization of structures and dynamic processes within the human body using ultrasound, providing image information for diagnosis across multiple clinical applications including fetal, abdominal, intra-operative, pediatric, small organs, cardiac, peripheral vascular, musculoskeletal, laparoscopic, and thoracic/pleural areas.
The device is a mobile diagnostic ultrasound system employing a wide range of probes (flat linear array, convex, sector array) with frequencies from 2 MHz to 30 MHz. It supports various high-quality ultrasound imaging modes including B mode, M mode, Continuous Wave, Color Doppler, Pulsed Wave Doppler, Power Doppler, Combination Doppler, Speckle-tracking, Tissue Harmonic Imaging, Shear wave elastography, Elastography, and Acoustic attenuation mapping. Software features include AI-supported functions such as automated initial contour tracing for left ventricle wall motion tracking and auto ejection fraction calculation, as well as advanced image transfer and network storage capabilities.
The device underwent risk analysis, verification, and validation activities including bench testing with phantoms, test data, and volunteer data to demonstrate that new and improved features meet established specifications and perform as intended. No clinical studies were required to demonstrate safety and efficacy. The device complies with applicable IEC standards and FDA guidance documents for ultrasound system marketing clearance and software content, including cybersecurity considerations.
No predicate devices specified
Submission
7/27/2021
FDA Approval
1/24/2022
Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.
We respect your privacy. Unsubscribe at any time.